Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-10-16 6:13 pm Sale | 2026-09-30 | 13G | BETTER HOME & FIN HLDG CO COM BETR | Integrated Core Strategies (US) LLC | 591,575 4.500% | -138,690 (-18.99%) | Filing History |
| 2026-10-16 5:23 pm Sale | 2026-09-30 | 13G | BRAZE, INC. CLASS A BRZE | Integrated Core Strategies (US) LLC | 1,547,832 1.400% | -2,836,557 (-64.70%) | Filing History |
| 2026-10-08 6:27 pm Purchase | 2026-09-30 | 13G | COLLEGIUM PHARMACEUTICAL INC C COLL | Integrated Core Strategies (US) LLC | 2,400,985 7.400% | 580,655 (+31.90%) | Filing History |
| 2026-10-05 6:23 pm Purchase | 2026-09-28 | 13G | FIRST HORIZON CORPORATION FHN | Integrated Core Strategies (US) LLC | 26,345,431 5.600% | 7,528,342 (+40.01%) | Filing History |
| 2026-09-22 6:35 pm Purchase | 2026-09-16 | 13G | BETTER HOME & FIN HLDG CO COM BETR | Integrated Core Strategies (US) LLC | 730,265 5.500% | 730,265 (New Position) | Filing History |
| 2026-09-04 5:35 pm Purchase | 2026-08-31 | 13G | KARYOPHARM THERAPEUTICS INC CO KPTI | Integrated Core Strategies (US) LLC | 1,297,297 5.700% | 785,726 (+153.59%) | Filing History |
| 2026-09-01 6:13 pm Purchase | 2026-08-26 | 13G | FORTRESS BIOTECH INC FBIO | Integrated Core Strategies (US) LLC | 1,778,561 5.300% | 1,778,561 (New Position) | Filing History |
| 2026-08-24 5:48 pm Purchase | 2026-08-17 | 13G | TENAYA THERAPEUTICS INC TNYA | Integrated Core Strategies (US) LLC | 11,581,565 5.200% | 11,581,565 (New Position) | Filing History |
| 2026-08-24 5:02 pm Purchase | 2026-08-17 | 13G | COLLEGIUM PHARMACEUTICAL INC C COLL | Integrated Core Strategies (US) LLC | 1,820,330 5.600% | 300,830 (+19.80%) | Filing History |
| 2026-08-14 5:04 pm Purchase | 2026-06-30 | 13G | SHARONAI HOLDINGS INC SHAZ | Integrated Core Strategies (US) LLC | 1,742,894 4.800% | 872,123 (+100.16%) | Filing History |
| 2026-08-13 7:34 pm Sale | 2026-06-30 | 13G | ZEPP HEALTH CORP ADR ZEPP | Integrated Core Strategies (US) LLC | 0 0.000% | -6,634,592 (Position Closed) | Filing History |
| 2026-08-11 6:56 pm Sale | 2026-06-30 | 13G | METALS ACQUISITION CORP II MTAL | Integrated Core Strategies (US) LLC | 1,630,000 7.100% | -300,000 (-15.54%) | Filing History |
| 2026-08-11 6:11 pm Sale | 2026-06-30 | 13G | ARDELYX INC ARDX | Integrated Core Strategies (US) LLC | 14,200,773 5.700% | -3,843,197 (-21.30%) | Filing History |
| 2026-08-10 5:05 pm Purchase | 2026-08-04 | 13G | LONGEVERON INC LGVN | Integrated Core Strategies (US) LLC | 155,364 5.200% | 155,364 (New Position) | Filing History |
| 2026-08-07 5:48 pm Purchase | 2026-07-31 | 13G | CHURCHILL CAPITAL CORP XIII UN XIIIU | Integrated Core Strategies (US) LLC | 3,368,778 8.100% | 3,368,778 (New Position) | Filing History |
| 2026-08-06 8:18 pm Purchase | 2026-06-30 | 13G | IMMUNIC INC IMUX | Integrated Core Strategies (US) LLC | 969,547 7.000% | 175,926 (+22.17%) | Filing History |
| 2026-08-05 4:45 pm Purchase | 2026-07-29 | 13G | T1 ENERGY INC. TE | Integrated Core Strategies (US) LLC | 12,346,674 4.400% | 12,346,674 (New Position) | Filing History |
| 2026-08-04 7:51 pm Purchase | 2026-06-30 | 13G | SPRUCE BIOSCIENCES INC SPRB | Integrated Core Strategies (US) LLC | 160,981 5.800% | 57,955 (+56.25%) | Filing History |
| 2026-08-03 7:47 pm Sale | 2026-06-30 | 13G | AMANAT ACQUISITION CORP USD CL AMAN | Integrated Core Strategies (US) LLC | 276,160 3.500% | -421,214 (-60.40%) | Filing History |
| 2026-08-03 5:47 pm Purchase | 2026-06-30 | 13G | REVIVA PHARMACEUTICALS HLDGS C RVPH | Integrated Core Strategies (US) LLC | 1,072,690 8.200% | 278,738 (+35.11%) | Filing History |